Associations between inflammatory markers and bone mineral density in lean pubertal girls by Jürimäe, Jaak et al.
ASSOCIATIONS BETWEEN INFLAMMATORY 
MARKERS AND BONE MINERAL DENSITY 
IN LEAN PUBERTAL GIRLS
 Jaak Jürimäe1, Anna-Liisa Tamm2, Liina Remmel1, 
Vallo Tillmann3
1Institute of Sport Sciences and Physiotherapy, Faculty of Medicine, 
University of Tartu, Tartu, Estonia
2Tartu Health Care College, Tartu, Estonia
3Institute of Clinical Medicine, Faculty of Medicine, University of Tartu, Tartu, Estonia
ABSTRACT
We investigated whether common inflammatory markers are associated 
with bone accumulation in lean pubertal girls. Thirty-four 10–12-year-
old lean girls at pubertal stages 2–4 were studied. Twelve inflammatory 
parameters [interleukin (IL)-2, IL-4, IL-6, IL-8, IL-10, vascular endothe-
lial growth factor, interferon-gamma (IFN-γ), tumour necrosis factor-
alpha, IL-1α, IL-1β, monocyte chemotactic protein-1 (MCP-1) and epi-
dermal growth factor] were measured from plasma samples. Whole body 
(WB), lumbar spine (LS) and femoral neck (FN) bone mineral density 
(BMD), and WB bone mineral content (BMC) were assessed by DXA. 
Plasma IFN-γ concentration was negatively correlated (p<0.05) with WB 
BMC (r=–0.45), WB BMD (r=–0.46) and FN BMD (r=–0.43). In addi-
tion, plasma IL–6 (r= –0.37; p<0.05), IL-1α (r=–0.40; p<0.05) and MCP-1 
(r=–0.38; p<0.05) concentrations were also negatively correlated to meas-
ured BMD values. The stepwise regression analysis showed that IFN-γ 
alone and together with IL-1α explained 18.6% and 27.6%, respectively, 
of the variability in WB BMD, while IL-1α and MCP-1 together explained 
25.5% of the variability in LS BMD, and IL-1α together with IFN-γ 
explained 34.1% of the variability in FN BMD. In conclusion, plasma 
IFN-γ, IL-6, IL-1α and MCP-1 concentrations were associated with 
BMD variables, suggesting that these cytokines may participate in bone 
accumu lation in lean pubertal girls.
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INTRODUCTION
Puberty is an important period for bone mineral accrual in children over 
a relatively brief period, influenced by genetic potential, endocrine status, 
nutritional factors, body composition and physical activity (PA) [6, 10, 15]. 
Puberty is also a period when a marked decline in PA occurs, which is typi-
cally accompanied by a significant weight gain [14]. Childhood obesity has 
been positively linked to bone mineral density (BMD) and bone mineral 
content (BMC) in sedentary pubertal girls [6, 15]. A positive effect of fat 
mass (FM) on bone mineral accrual has been attributed to a combination of 
mechanical load exerted on the skeleton by FM [6] and by the adipose tissue 
modulated blood biochemical signals [15]. We have shown that relatively 
low adiposity in boys in addition to decline in PA is a risk factor for low bone 
mineral accrual in puberty [28]. 
It has been previously shown that excess adiposity has been related to 
low-grade systemic inflammation [2, 21], and many inflammatory para-
meters such as interleukin (IL)-6, IL-8, interferon-gamma (IFN-γ), mono-
cyte chemotactic protein-1 (MCP-1) and high-sensitive C-reactive protein 
(hsCRP) are elevated in overweight and obese children [26]. While many 
of these markers have been inversely related to adult bone health [1, 4, 
13], there is a very limited knowledge of the possible role of inflammatory 
markers in the association between body adipose tissue and bone mineral 
accrual in normal children during growth and maturation [9, 27]. Some 
inflammatory markers have been reported to be negatively associated with 
bone mineral values in normal weight children [9, 27], while in contrast a 
positive correlation between circulating IFN-γ concentration and whole-
body (WB) BMD was found among overweight pubertal boys [27]. It was 
speculated that IFN-γ may contribute to low-grade inflammation in obesity 
[26] and could be a link between increased FM and higher BMD in over-
weight pubertal boys [27], whereas the knowledge about the role of differ-
ent inflammatory markers in lean normally growing children is limited. To 
our best knowledge, the possible role of different inflammatory markers in 
bone health in lean female girls during puberty has not been studied before. 
The aim of the present study was to investigate the possible associations 
between a panel of simultaneously measured 12 inflammatory markers and 
bone mineral parameters in lean pubertal girls.
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MATERIALS AND METHODS
Participants
Thirty-four healthy Estonian pubertal girls participated in this study. The 
participants were recruited from physical education classes at the local 
secondary schools that they had twice a week. Participation only in school 
physical education classes was inclusion criteria for subjects as they did not 
participate in any training groups. None of the participants was receiving 
any medications or had any recent acute illnesses or a history of bone or 
renal diseases. All procedures were approved by the Medical Ethics Com-
mittee of the University of Tartu, Estonia and were explained to the children 
and their parents, who signed an informed consent form. 
Anthropometry and sexual maturation 
Body height was measured with the use of a Martin metal anthropometer 
to the nearest 0.1 cm according to the standard technique, and body mass 
was measured with minimal clothing to the nearest 0.05 kg with a medical 
electronic scale (A&D Instruments Ltd., Abingdon, UK). Body mass index 
(BMI) was also calculated (kg/m2). Pubertal development was assessed by 
self-report using an illustrated questionnaire according to the Tanner clas-
sification method [25], which has been validated [17] and used previously 
in our laboratory in different studies [8, 11, 19]. The girls were given photo-
graphs, figures and descriptions of breast and pubic hair development stages 
and asked to choose the one that most accurately reflected their appearance. 
In the case of discrepancies between the two variables, greater emphasis for 
the determination of the Tanner stage was placed on the degree of breast 
development. 
Bone mineral assessments
Bone mineral density (BMD, g/cm2) of the whole body (WB), lumbar spine 
(LS), femoral neck (FN), and the WB bone mineral content (BMC) were 
measured by DXA using the DPX-IQ densitometer (Lunar Corporation, 
Madison, Wisc., USA) equipped with proprietary software, version 3.6 [11, 
20]. Participants were scanned in light clothing while lying flat on their 
backs with arms on their sides. The fast scan mode and standard subject 
positioning were used for whole-body measurements and analysis was per-
formed using an extended analysis option. The same experienced  examiner 
 evaluated all DXA measurements and results. Coefficients of variation (CVs) 
for BMC and BMD measurements were less than 2%.
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Blood analysis
Venous blood samples were drawn between 7:30 and 8:30 a.m. after an over-
night fast from an antecubital vein with the participant sitting in the upright 
position. The plasma was separated and frozen at –20 °C. All plasma samples 
were measured simultaneously within 6 months of collection. The follow-
ing markers of inflammation were measured: interleukin (IL)-2, IL-4, IL-6, 
IL-8, IL-10, vascular endothelial growth factor (VEGF), interferon-gamma 
(IFN-γ), tumour necrosis factor-alpha (TNF-α), IL-1α, IL-1β, monocyte 
chemotactic protein-1 (MCP-1) and epidermal growth factor (EGF) [26]. 
The Cytokine and Growth Factors Special High-Sensitivity Array of the Bio-
chip system (Randox Laboratories Ltd, Crumlin, UK) was used for simulta-
neous quantitative detection of multiple, related cytokine immunoassays in 
parallel from a single sample. None of the inflammation markers were below 
detection limits. For all measured markers, intra-assay CV was 5.1–8.5%, 
and inter-assay CV was between 5.8–9.9% [26].
Statistical analysis
All statistical analyses were performed using SPSS, version 20.0 (SPSS Inc, 
Chicago. IL, USA). Data are presented as mean ± standard derivation (SD) 
and are also described by median and interquartile range. Relationships 
between inflammatory markers and measured bone indices were assessed 
by Pearson correlation analysis. Stepwise multiple regression analysis was 
performed to determine the independent effect of BMI and 12 inflam matory 
markers on measured BMC and BMD variables [27]. The level of signi-
ficance was set at p<0.05. 
RESULTS
The main physical examination and bone mineral data of participants as well 
as the results of serum inflammatory biomarkers are presented in Table 1. 
Nineteen girls were at pubertal stage 2, 12 girls at pubertal stage 3 and 3 
girls at pubertal stage 4. Plasma IFN-γ concentration was negatively corre-
lated (p<0.05) with WB BMC (r=–0.45), WB BMD (r=–0.46) and FN BMD 
(r=–0.43). In addition, IL-6 was negatively correlated (p<0.05) with WB 
BMC (r=–0.37), WB BMD (r=–0.41), LS BMD (r=–0.43) and FN BMD 
(r=–0.39), while IL-1α was negatively related to (p<0.05) WB BMD 
(r=–0.40), LS BMD (r=–0.44) and FN BMD (r=–0.51). Plasma MCP-1 was 
also correlated to LS BMD (r=–0.38; p<0.05). All other correlations between 
12 inflammatory markers and bone mineral values were not significant. 
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The stepwise multiple regression analysis demonstrated that BMI was the 
most significant predictor of WB BMC, explaining 25.1% of the variability 
in WB BMC, while IFN-γ alone and together with IL-1α explained 18.6% 
and 27.6%, respectively, of the variability of WB BMD in lean pubertal girls 
(Table 2). In addition, IL-1α explained 16.9% and 23.6% of the variability 
in LS and FN BMD values, respectively. While IL-1α and MCP-1 together 
explained 25.5% of the variability in LS BMD, and IL-1α together with IFN-γ 
explained 34.1% of the variability in FN BMD (Table 2).
Table 1. Physical and inflammatory biomarkers characteristics of the participants (n=34).
Variable Mean±SD Median (interquartile range)
Age (yrs) 11.2±0.5 11.3 (10.7–11.7)
Height (cm) 148.1±5.7 147.9 (143.9–153.9)
Body mass (kg) 39.8±7.3 39.9 (33.4–44.6)
BMI (kg/m2) 18.2±2.9 17.9 (15.7–19.6)
WB BMC (g) 1433.7±254.2 1403.5 (1231.6–1629.3)
WB BMD (g/cm2) 0.925±0.059 0.925 (0.877–0.963)
LS BMD (g/cm2) 0.836±0.123 0.831 (0.741–0.902)
FN BMD (g/cm2) 0.832±0.121 0.801 (0.753–0.902)
IL-2 (pg/ml) 2.1±2.3 2.1 (1.2–5.1)
IL-4 (pg/ml) 2.2±1.1 2.0 (1.6–2.5)
IL-6 (pg/ml) 1.8±2.1 0.9 (0.6–2.0)
IL-8 (pg/ml) 11.5±5.6 10.6 (6.4–14.3)
IL-10 (pg/ml) 1.9±1.7 1.4 (0.8–2.5)
VEGF (pg/ml) 66.2±42.8 48.9 (38.3–90.2)
IFN-γ (pg/ml) 0.9±0.8 0.7 (0.3–1.3)
TNF-α (pg/ml) 3.6±1.4 3.7 (2.7–4.1)
IL-1α (pg/ml) 0.3±0.2 0.2 (0.1–0.3)
IL-1β (pg/ml) 2.0±1.2 1.6 (1.3–2.4)
MCP-1 (pg/ml) 152.0±46.4 142.7 (116.6–182.5)
EGF (pg/ml) 36.4±14.9 37.1 (27.5–44.1)
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Table 2. Results of stepwise multiple regression analysis with whole body BMC, whole 
body BMD, lumbar spine BMD and femoral neck BMD as dependent variables, and BMI 
and measured 12 inflammatory markers as independent variables (R2 x 100; p<0.05).
Dependent variables Independent variables R2 x 100 p
Whole body BMC
BMI 25.1 0.001
BMI, IL-1β 36.0 0.0001
Whole body BMD
IFN-γ 18.6 0.006
IFN-γ, IL-1α 27.6 0.003
Lumbar spine BMD
IL-1α 16.9 0.009
IL-1α, MCP-1 25.5 0.004
Femoral neck BMD
IL-1α 23.6 0.002
IL-1α, IFN-γ 34.1 0.001
DISCUSSION
Possible associations of 12 inflammatory parameters with bone mineral 
characteristics were studied in 34 lean pubertal girls. Plasma IFN-γ, IL-6, 
IL-1α and MCP-1 concentrations were negatively associated with different 
bone mineral variables, suggesting that these pro-inflammatory cytokines 
may participate in bone accumulation in lean pubertal girls.
We found a negative independent association of plasma IFN-γ concen-
tration with WB BMD (see Table 2). In addition, circulating IFN-γ level was 
also inversely correlated with other measured BMC and BMD values. To 
our best knowledge, no studies have previously investigated the associations 
between plasma IFN-γ concentration and BMD variables in girls  during 
puberty. In accordance with the results of the present study, markers of 
IFN-γ-mediated inflammation were inversely related to bone mineral values 
in the healthy elderly, but not middle-aged men and women [1], while other 
study demonstrated no relationship between IFN-γ concentration and BMD 
variables in healthy people [16]. In our previous study, we found that serum 
IFN-γ concentration was positively associated with WB BMD in overweight 
boys, while no such a relationship was found in normal weight boys [27]. 
It was suggested that IFN-γ may contribute to inflammation in obesity and 
could be a link between increased FM and higher WB BMD in pubertal boys 
[27]. As circulating IFN-γ concentrations in studied pubertal lean girls were 
much lower than corresponding values in overweight pubertal boys [27], it 
is likely that the association between IFN-γ and BMD in growing children 
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is dependent on the amount of body adiposity. However, further studies in 
subjects with wide range of BMI values are needed before any conclusions 
can be drawn.
IFN-γ is produced locally in bone tissue by cells of immune origin and 
mesenchymal stem cells [5, 24]. It can either inhibit osteoclast formation 
or enhance osteoclastogenesis according to the conditions to which the 
 osteoclast precursors are exposed [24]. In addition, IFN-γ also promotes the 
fusion of pre-fusion osteoclasts to form multinucleated mature osteoclasts 
[29]. In an animal model that mimics inflammation and estrogen deficiency, 
IFN-γ indirectly stimulates osteoclast formation and bone loss by stimulat-
ing antigen-dependent T cell activation [7]. Further studies indicated that 
RANKL upregulation is mediated by IFN-γ inducible protein-10 in T-cells 
[12]. A study by Ayon Haro et al. [3] confirmed that IFN-γ together with 
lipopolysaccharides enhanced osteoclast formation and therefore likley 
increased bone resorption. Our results are in accordance with these  findings 
[3], where IFN-γ was inversely associated with bone mineral variables in 
lean pubertal girls. However, IFN-γ receptor knockout mice exhibited a 
reduction in bone volume and significant changes in cortical and trabecular 
bone structure typical for osteoporotic phenotype [5]. Administration of 
IFN-γ to wild-type ovariectomized female mice improved bone mass and 
microarchitecture and rescued osteoporosis [5]. Taken together, it has been 
suggested that these conflicting results may indicate a difference between 
local versus systemic impact of IFN-γ on bones [1].
We also found that plasma IL-6, IL-1α and MCP-1 levels were nega-
tively correlated with measured bone mineral variables indicating that these 
pro-inflammatory cytokines participate in bone remodelling. It has been 
proposed that circulating IL-6 may play a role in the mechanism leading 
to either a decrease or lack of the expected increase in BMD during ado-
lescence [18]. Specifically, inflammatory cytokines such as IL-1, IL-6 and 
TNF-α induce bone resorption by controlling the differentiation and  activity 
of osteoblasts and osteoclasts, which subsequently leads to increased bone 
turnover and decreased BMD [13, 22, 23]. In healthy premenopausal women, 
the production of IL-1, IL-6 and TNF-α in peripheral blood mononuclear 
cells was positively correlated with vertebral bone loss [22], whereas serum 
IL-6 concentration predicted femoral bone loss [23]. To our best knowledge, 
there have been no studies investigating the possible association between 
MCP-1 and BMD in pubertal girls. Our study found a negative correlation 
between plasma MCP-1 and LS BMD. The recent study by Yan et al. [30], 
where mice deficient in MCP-1 exhibited increases in vertebrae trabecular 
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thickness and BMD compared to wild-type mice, supported our negative 
correlation between MCP-1 and LS BMD in lean pubertal girls.
In conclusion, plasma IFN-γ, IL-6, IL-1α and MCP-1 concentrations 
were negatively associated with bone mineral variables, suggesting that these 
cytokines may participate in bone accumulation in lean pubertal girls.
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